Integra LifeSciences Holdings (IART) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Integra LifeSciences Holdings (IART) has a cash flow conversion efficiency ratio of 0.009x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.80 Million) by net assets ($1.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IART stock market capitalisation for the company's overall valuation and market capitalisation.
Integra LifeSciences Holdings - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Integra LifeSciences Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Integra LifeSciences Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integra LifeSciences Holdings ranked by their cash flow conversion efficiency. Explore IART cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ribo Fashion Group Co Ltd
SHG:603196
|
0.024x |
|
United Corporations Limited
TO:UNC
|
0.004x |
|
Lanzhou LS Heavy Equipment Co
SHG:603169
|
-0.003x |
|
Gansu Yasheng Industrial Group Co Ltd
SHG:600108
|
0.005x |
|
Hunan Yujing Machinery Co Ltd Class A
SHE:002943
|
0.113x |
|
Taiwan Hon Chuan Enterprise Co Ltd
TW:9939
|
0.099x |
|
Cadre Holdings Inc
NYSE:CDRE
|
0.067x |
|
Universal Technical Institute Inc
NYSE:UTI
|
0.030x |
Annual Cash Flow Conversion Efficiency for Integra LifeSciences Holdings (1995–2025)
The table below shows the annual cash flow conversion efficiency of Integra LifeSciences Holdings from 1995 to 2025. View IART share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.04 Billion | $50.38 Million | 0.048x | -42.33% |
| 2024-12-31 | $1.55 Billion | $129.38 Million | 0.084x | -5.01% |
| 2023-12-31 | $1.59 Billion | $139.96 Million | 0.088x | -39.86% |
| 2022-12-31 | $1.80 Billion | $264.47 Million | 0.147x | -20.96% |
| 2021-12-31 | $1.68 Billion | $312.43 Million | 0.185x | +37.82% |
| 2020-12-31 | $1.51 Billion | $203.83 Million | 0.135x | -17.63% |
| 2019-12-31 | $1.42 Billion | $231.43 Million | 0.163x | +12.55% |
| 2018-12-31 | $1.38 Billion | $199.68 Million | 0.145x | +21.93% |
| 2017-12-31 | $962.31 Million | $114.54 Million | 0.119x | -14.14% |
| 2016-12-31 | $839.67 Million | $116.41 Million | 0.139x | +10.26% |
| 2015-12-31 | $751.44 Million | $94.48 Million | 0.126x | +11.45% |
| 2014-12-31 | $704.32 Million | $79.46 Million | 0.113x | +41.94% |
| 2013-12-31 | $670.18 Million | $53.27 Million | 0.079x | -29.91% |
| 2012-12-31 | $517.77 Million | $58.72 Million | 0.113x | -46.45% |
| 2011-12-31 | $492.64 Million | $104.33 Million | 0.212x | +0.29% |
| 2010-12-31 | $499.96 Million | $105.57 Million | 0.211x | -34.41% |
| 2009-12-31 | $444.88 Million | $143.24 Million | 0.322x | +55.33% |
| 2008-12-31 | $350.21 Million | $72.59 Million | 0.207x | +14.79% |
| 2007-12-31 | $260.43 Million | $47.03 Million | 0.181x | -25.42% |
| 2006-12-31 | $296.16 Million | $71.70 Million | 0.242x | +23.43% |
| 2005-12-31 | $289.82 Million | $56.85 Million | 0.196x | +54.92% |
| 2004-12-31 | $307.82 Million | $38.98 Million | 0.127x | -2.37% |
| 2003-12-31 | $268.53 Million | $34.83 Million | 0.130x | +0.39% |
| 2002-12-31 | $247.60 Million | $31.98 Million | 0.129x | +67.89% |
| 2001-12-31 | $204.06 Million | $15.70 Million | 0.077x | +183.43% |
| 2000-12-31 | $53.78 Million | $-4.96 Million | -0.092x | -240.18% |
| 1999-12-31 | $38.00 Million | $2.50 Million | 0.066x | +121.08% |
| 1998-12-31 | $31.40 Million | $-9.80 Million | -0.312x | -41.43% |
| 1997-12-31 | $35.80 Million | $-7.90 Million | -0.221x | -27.99% |
| 1996-12-31 | $46.40 Million | $-8.00 Million | -0.172x | +46.43% |
| 1995-12-31 | $17.40 Million | $-5.60 Million | -0.322x | -- |
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural … Read more